Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
ACS Medicinal Chemistry Letters|February 5, 2014
Potent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffoldZhongsheng Zhang, Kayode K Ojo, Ramasubbarao Vidadala, et al.
Journal of Medicinal Chemistry|February 29, 2012
Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1Eric T Larson, Kayode K Ojo, Ryan C Murphy, et al.
Protein Science : a Publication of the Protein Society|January 14, 2020
Structures of glyceraldehyde 3-phosphate dehydrogenase in Neisseria gonorrhoeae and Chlamydia trachomatisKayleigh F Barrett, David M Dranow, Isabelle Q Phan, et al.
Plos One|March 3, 2016
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active CompoundsGregory J Crowther, Heidi K Hillesland, Katelyn R Keyloun, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Deborah A Schaefer, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C Sprenger, et al.
Pageof 11